Where Ireland's physiotherapy cover is thinnest
August 2026 / MSK / ROI
More analyses
Where England's physiotherapy supply is thinnest and NHS orthopaedic waits are longest
July 2026 / MSK / UK
Chronic pain in England has a clear shape, and women carry more of it
June 2026 / MSK / UK
Brand Amplification in Pain Management: Share of UK MSK Provider Mentions, April 2026
April 2026 / MSK / UK
About this market
Physiotherapy, osteopathy, rheumatology and pain management sit in one Rare.Monitor classification rather than in four separate provider markets. Across all approved UK locations, Rare.Monitor records musculoskeletal provision at 39,451 locations, linked to 7,874 distinct owner records, on figures read on 20 August 2026. NHS waiting-time and workforce figures in the analyses below come from published NHS and Office for National Statistics sources, not from Rare.Monitor.
FAQ
Frequently asked questions
Questions answered from Rare.Monitor data, figures read 20 August 2026.
How many UK locations record private musculoskeletal treatment?
Rare.Monitor records musculoskeletal provision at 39,451 approved UK locations. The tag is detected from what each location publishes about its own treatments, so the count records private provision rather than measuring the whole market, and it does not include NHS musculoskeletal services. Source: Rare.Monitor, figures read 20 August 2026.What counts as musculoskeletal (MSK) provision in Rare.Monitor data?
Musculoskeletal provision in Rare.Monitor covers physiotherapy, osteopathy and chiropractic, orthopaedics, rheumatology, sports medicine, soft tissue injury and musculoskeletal pain management, recorded from what each UK location publishes about its own treatments. A location carrying any of those is counted once in this hub's figure. Source: Rare.Monitor.How is UK private musculoskeletal care structured by ownership?
Rare.Monitor links the 39,451 approved UK locations recording musculoskeletal provision to 7,874 distinct owner records. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so these figures do not show how concentrated ownership is or how many providers operate from a single site. Locations approved most recently have not yet been matched to an owner record, so 7,874 counts the owners matched so far rather than every owner behind these locations. Source: Rare.Monitor, figures read 20 August 2026.What does Rare.Monitor track in the musculoskeletal segment?
Rare.Monitor tracks treatment classifications, brand mentions and ownership links across more than 230,000 reportable locations in the United Kingdom and Republic of Ireland (ROI). For musculoskeletal care that covers which treatments each UK location publishes, which equipment and treatment brands it names, and which organisation owns it. Records are built from what each location publishes, so figures are restated on each new market read. Source: Rare.Monitor, platform figures read 4 August 2026.Does Rare.Monitor cover NHS musculoskeletal services as well as private ones?
Rare.Monitor records private provision only, built from what each location publishes about its own treatments. Where an analysis on this page reports NHS waiting times or NHS workforce supply, those figures come from published NHS and Office for National Statistics sources rather than from Rare.Monitor, and the two are not counted on the same basis. Source: Rare.Monitor.
Methodology: Rare.Monitor is a private-market dataset, built on what each location publishes about its own treatments rather than on an official market survey, so a count records provision rather than measuring the whole market. Market figures on this page were read on 20 August 2026, in one read. Rare.Monitor records musculoskeletal provision at 39,451 approved UK locations, linked to 7,874 distinct owner records over the same locations in the same read. Musculoskeletal here covers physiotherapy, osteopathy and chiropractic, orthopaedics, rheumatology, sports medicine, soft tissue injury and musculoskeletal pain management. Locations in this cohort were approved into the dataset between February and August 2026. Rare.Monitor records private provision only. The NHS waiting-time and workforce figures in the analyses linked below come from published NHS and Office for National Statistics sources, not from Rare.Monitor, and the two are not counted on the same basis. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so they support no statement about how concentrated ownership is. Provider matching runs as a later stage, so locations approved most recently are not yet matched to an owner record, and the count covers the owners matched so far rather than every owner behind these locations. The classification is detected from website text rather than confirmed by a regulator, so a count carries some records the detection has placed wrongly. Most records have not yet had a full treatment re-scrape, so the count records the locations detected so far rather than every UK location offering these treatments. Classification passes for the cohort fall in a rolling nine to ten week window rather than on one fixed collection date. Platform-wide figures were read separately on 4 August 2026 and are not comparable with the market figures above. Figures in the linked analyses below come from earlier snapshots measured on their own bases, so they are not a trend series with the figures on this page. Source: Rare.Monitor.